webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

m-PEG6-SS-PEG6-methyl

  CAS No.: 1007386-15-3   Cat No.: BADC-00875   Purity: >98% 4.5  

m-PEG6-SS-PEG6-methyl is a cleavable disulfide-containing PEG ADC linker providing enhanced hydrophilicity and controlled intracellular payload release in antibody-drug conjugates.

m-PEG6-SS-PEG6-methyl

Structure of 1007386-15-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C26H54O12S2
Molecular Weight
622.83
Shipping
Room temperature
Shipping
-20 °C, protect from light.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
1,1'-Dithiobis(3,6,9,12,15,18-hexaoxanonadecane)
IUPAC Name
Canonical SMILES
COCCOCCOCCOCCOCCOCCSSCCOCCOCCOCCOCCOCCOC
InChI
InChI=1S/C26H54O12S2/c1-27-3-5-29-7-9-31-11-13-33-15-17-35-19-21-37-23-25-39-40-26-24-38-22-20-36-18-16-34-14-12-32-10-8-30-6-4-28-2/h3-26H2,1-2H3
InChIKey
BGUPYWMPJFBFCS-UHFFFAOYSA-N
Solubility
10 mm in DMSO
Shelf Life
≥ 2 years
Shipping
Room temperature
Storage
-20 °C, protect from light.

m-PEG6-SS-PEG6-methyl is a bifunctional polyethylene glycol derivative with applications in drug delivery and biomaterials science. Here are some key applications of m-PEG6-SS-PEG6-methyl:

Drug Delivery Systems: m-PEG6-SS-PEG6-methyl is utilized in the development of advanced drug delivery systems, particularly for targeted therapies. This compound serves as a linker in prodrug formulations, where the cleavable disulfide bond allows for controlled drug release in the reducing environment of tumor cells or specific tissues. Its application enhances the therapeutic index of drugs, reducing systemic toxicity and improving patient outcomes.

Bioconjugation: In bioconjugation techniques, m-PEG6-SS-PEG6-methyl is used as a spacer or linker to attach bioactive molecules, such as enzymes, antibodies, or peptides, to surfaces or other moieties. The presence of the cleavable disulfide bond offers the advantage of reversible conjugation, which can be crucial in applications requiring triggered release or iterative surface modifications.

Nanoparticle Functionalization: m-PEG6-SS-PEG6-methyl is employed to functionalize nanoparticles, giving them stealth properties while allowing for targeted delivery. The PEG chains provide a hydrophilic shell that reduces opsonization and prolongs systemic circulation, while the disulfide bond can ensure payload release upon reaching the target site.

Biodegradable Hydrogels: The compound is also integral in the synthesis of biodegradable hydrogels for tissue engineering and regenerative medicine. By incorporating m-PEG6-SS-PEG6-methyl, these hydrogels can exhibit tunable degradation rates through the cleavage of disulfide bonds in response to the cellular environment. This property facilitates controlled nutrient delivery and tissue integration, promoting healing and tissue regeneration.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB | Ala-Ala-Asn-PAB | Fmoc-PEG4-Ala-Ala-Asn-PAB | Azido-PEG5-Ala-Ala-Asn-PAB | Fmoc-GGFG-Glycolic acid | Fmoc-GGFG-OH | DC4 | DACN(Tos2) | Anetumab ravtansine | m-PEG6-SS-PEG6-methyl
Send Inquiry
Verification code
Inquiry Basket